Table 4.
Survival rate after 11 days of in vivo efficacy testing.
| Dosage (mg/kg) | Sarcosine-aniline hybrid | Sarcosine | 3-Chloro-4-(4-chlorophenoxy) aniline | Artesunate | Artesunate-aniline hybrid | Chloroquine |
|---|---|---|---|---|---|---|
| 10 | 3 | 1 | 4 | 5 | 3 | 5 |
| 5 | 2 | 2 | 2 | 3 | 2 | 4 |
| 2.5 | 1 | 1 | 3 | 4 | 3 | 4 |
| 1.25 | 1 | 1 | 3 | 3 | 3 | 3 |
| 0.625 | 1 | 0 | 1 | 2 | 1 | 3 |